Core Viewpoint - The article discusses the innovative approach of Yike Biotech in reducing the cost of PHA (polyhydroxyalkanoates) production to compete with petroleum-based materials, emphasizing the use of non-food plant oils as raw materials [3][4][9]. Group 1: Industry Background - The biodegradable materials market, including PLA and PBAT, has faced challenges such as overcapacity and performance limitations, leading to a decline in production rates [6][7]. - PHA is highlighted for its advantages, including marine biodegradability, heat resistance up to 100°C, and excellent barrier properties, with the global market expected to reach $367 million by 2030 [6][8]. Group 2: Company Overview - Yike Biotech was founded in June 2025 by Dr. Wilson Ling, who aims to revolutionize PHA production using non-food oils, specifically Pongamia oil, to significantly lower costs [9][10]. - The company has completed laboratory and pilot-scale validations of its production process and is the first globally to hold a PCT patent for PHA production [37]. Group 3: Cost Reduction Strategy - The raw material cost constitutes over 50% of PHA production costs, making it essential to lower these costs. Traditional sugar-based routes have a conversion rate of only 30%, leading to high costs [27][28]. - By using Pongamia oil, which has a conversion rate of over 80%, Yike Biotech can reduce PHA production costs by 30-50% compared to sugar-based methods [36]. Group 4: Technical and Market Development - Yike Biotech plans to focus on medical products for the Australian market, where demand is high, and the approval process is faster compared to other regions [38]. - The company aims to establish a production line in China that can replace 15,000 to 20,000 tons of petroleum-based plastics annually, with plans for further expansion [39].

DT产业研究院 | 宜可生物 创始人 文 | 陈竞芬 "有关环保的事，我们要第一个先做, 还必须做到最好。Ecopha=Eco+ Alpha=Eco+ PHA。 " 眼前这位头发微白却目光如炬的科学家，二十年间辗转新加坡、马来西亚、澳大利亚，如今回到中 国，创立 宜可生物 ，只为攻克一个难题： 把PHA的成本降到能与石油基材料竞争 。 他将如何做到大幅降低成本？ 近日， DT新材料产业研究院行业分析师陈竞芬 对 宜可生物创始人林理坪博士 进行了独家专访， 他不仅分享了其在海外科研和创业，以及回国创业的初心，更分享了宜可生物将如何降低PHA成 本，为行业提供极具价值的专业洞见。此前，DT新材料第一时间报道了宜可生物的成立。 全球第一家专利！又一企业布局 PHA 生物塑料！ 左：宜可生物创始人 林理坪（Wilson Ling）博士，右：DT新材料行业分析师 陈竞芬 "限塑令"后，PLA、PBAT等可降解材料曾短暂炙手可热，随即陷入产能过剩（2024年PBAT开工率 不足20%）。更深层的问题是性能瓶颈：PLA/PBAT因耐热性差（60-70℃）、降解依赖工业堆肥， 难替代传统石油基塑料，如全球用量最大的塑料PP、 ...